CONMED Corp Goodwill & Intangibles Disclosure
| 2025 | 2024 | ||||||||||
| Balance as of January 1, | $ | 805,358 | $ | 806,844 | |||||||
Foreign currency translation and other adjustments | 1,653 | (1,486) | |||||||||
| Balance as of December 31, | $ | 807,011 | $ | 805,358 | |||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||
| Weighted Average Amortization Period (Years) | Gross Carrying Amount | Accumulated Amortization | Gross Carrying Amount | Accumulated Amortization | ||||||||||||||||||||||
| Intangible assets with definite lives: | 22 | |||||||||||||||||||||||||
| Customer and distributor relationships | 24 | $ | 370,068 | $ | (221,904) | $ | 369,774 | $ | (205,013) | |||||||||||||||||
| Sales representation, marketing and promotional rights | 25 | 149,376 | (84,000) | 149,376 | (78,000) | |||||||||||||||||||||
| Patents and other intangible assets | 15 | 87,029 | (57,685) | 85,392 | (55,802) | |||||||||||||||||||||
| Developed technology | 18 | 317,904 | (65,281) | 320,204 | (54,812) | |||||||||||||||||||||
Intangible assets with indefinite lives: | ||||||||||||||||||||||||||
| Trademarks and tradenames | 86,544 | — | 86,544 | — | ||||||||||||||||||||||
| $ | 1,010,921 | $ | (428,870) | $ | 1,011,290 | $ | (393,627) | |||||||||||||||||||
| Amortization included in expense | Amortization recorded as a reduction of revenue | Total | |||||||||||||||
| 2026 | $ | 29,311 | $ | 6,000 | $ | 35,311 | |||||||||||
| 2027 | 30,731 | 6,000 | 36,731 | ||||||||||||||
| 2028 | 33,831 | 6,000 | 39,831 | ||||||||||||||
| 2029 | 33,024 | 6,000 | 39,024 | ||||||||||||||
| 2030 | 34,502 | 6,000 | 40,502 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 17, 2026 | Showing above |
| 2024 | Feb 18, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 21, 2023 | |
| 2021 | Feb 22, 2022 | |
| 2020 | Feb 22, 2021 | |
| 2019 | Feb 24, 2020 | |
| 2018 | Feb 25, 2019 | |
| 2017 | Feb 26, 2018 | |
| 2016 | Feb 27, 2017 | |
| 2015 | Feb 23, 2016 | |
About Goodwill & Intangibles Disclosures
Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.
Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.